213316-32-6

Basic information

• Product Name: Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, (1R,2S)-rel- (9CI)
• Synonyms: Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, (1R,2S)-rel- (9CI);Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, (1R,2S)-rel-;NBJXCTLFPNBZSG-HTRCEHHLSA-N
• CAS NO: 213316-32-6
• Molecular Formula: C8H13NO2
• Molecular Weight: 155.196
• Product Categories: CARBOXYLICESTER;GLYCINESCAFFOLD
• Mol File: 213316-32-6.mol
• Article Data: 33

Chemical Properties

• Boiling Point: 189.675°C at 760 mmHg
• Flash Point: 61.357°C
• Appearance: /
• Density: 1.156g/cm³
• Vapor Pressure: 0.563mmHg at 25°C
• Refractive Index: 1.564
• PKA: 6.27±0.40(Predicted)
• CAS DataBase Reference: Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, (1R,2S)-rel- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, (1R,2S)-rel- (9CI)(213316-32-6)
• EPA Substance Registry System: Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, (1R,2S)-rel- (9CI)(213316-32-6)

Safety Data

• Hazardous Substances Data: 213316-32-6(Hazardous Substances Data)

Usage

General Description

Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, (1R,2S)-rel- (9CI) is a chemical compound with a molecular formula C7H11NO2. It is a derivative of cyclopropanecarboxylic acid and is classified as an ethyl ester. Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, (1R,2S)-rel- (9CI) contains an amino group and an ethenyl group, and its stereochemistry is designated as (1R,2S)-rel-. It is commonly used in chemical synthesis and research as a reagent and intermediate. The properties and uses of this compound in various industries and applications may vary depending on the specific stereochemistry and the reactions in which it is involved.

InChI:InChI=1/C8H13NO2/c1-3-6-5-8(6,9)7(10)11-4-2/h3,6H,1,4-5,9H2,2H3/t6-,8-/m1/s1

Upstream product

• 821-06-7 (E)-1,4-dibromobutene 
• 133038-44-5 [(benzylidene)amino]acetic acid ethyl ester 
• 69555-14-2 ethyl N-diphenylmethylene glycine 
• 213316-49-5 (R)-t-butoxycarbonylamino-2-vinyl-cyclopropane carboxylic acid ethyl ester 
• 40682-54-0 ethyl N-benzylideneglycinate 
• 681807-60-3 (1R,2S)-ethyl 1-amino-2-vinylcyclopropanecarboxylate hydrochloride 
• 1393095-18-5 (E)-ethyl 1-(benzylideneamino)-2-vinylcyclopropanecarboxylate 
• 1023795-84-7 C₂₁H₂₁NO₂ 
• 787548-29-2 (1R,2S)/(1S,2R) 1-amino-2-vinylcyclopropane carboxylic acid ethyl ester 
• 259217-95-3 N-Boc-(1R,2S)-1-amino-2-vinylcyclopropane carboxylic acid ethyl ester 
• 213316-32-6 rac-(1R,2S)-1-amino-2-vinylcyclopropanecarboxylic acid ethyl ester 
• 259214-54-5 (trans)-ethyl 1-amino-2-vinylcyclopropanecarboxylate hydrochloride 
• 28509-24-2 tert-butylmethyl ether 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 213316-49-5 (1RS,2SR)-ethyl 2-vinyl-1-(tert-butoxycarbonylamino)cyclopropanecarboxylate 
• 159622-09-0 (1R,2S)-1-tert-butoxycarbonylamino-2-vinyl-cyclopropanecarboxylic acid methyl ester 
• 259214-54-5 (trans)-ethyl 1-amino-2-vinylcyclopropanecarboxylate hydrochloride 
• 259217-95-3 N-Boc-(1R,2S)-1-amino-2-vinylcyclopropane carboxylic acid ethyl ester 
• 924307-75-5 (1S,2R)-ethyl 2-vinyl-1-(tert-butoxycarbonylamino)cyclopropanecarboxylate 
• 862119-82-2 (2S,4R)-tert-butyl 2-((1R,2S)-1-(ethoxycarbonyl)-2-vinylcyclopropylcarbamoyl)-4-hydroxypyrrolidine-1-carboxylate 
• 159700-58-0 (1RS,2SR)-2-vinyl-1-aminocyclopropanecarboxylic acid 
• 1044559-89-8 cyclopropanesulfonic acid [14-(4-methoxy-benzyl)-18-(6-methoxy-2-phenyl-pyrimidin-4-yloxy)-2,15-dioxo-3,14,16-triaza-tricyclo[14.3.0.0*4,6*]nonadec-7-ene-4-carbonyl]amide 
• 1044559-83-2 14-(4-methoxy-benzyl)-18-(6-methoxy-2-phenyl-pyrimidin-4-yloxy)-2,15-dioxo-3,14,16-triaza-tricyclo[14.3.0.0*4,6*]nonadec-7-ene-4-carboxylic acid ethyl ester 
• 1044559-86-5 14-(4-methoxybenzyl)-18-(6-methoxy-2-phenylpyrimidin-4-yloxy)-2,15-dioxo-3,14,16-triaza-tricyclo[14.3.0.0*4,6*]nonadec-7-ene-4-carboxylic acid 
• 1044558-74-8 cyclopropanesulfonic acid [18-(6-methoxy-2-phenylpyrimidin-4-yloxy)-2,15-dioxo-3,14,16-triaza-tricyclo[14.3.0.0*4,6*]nonadec-7-ene-4-carbonyl]-amide 
• 922726-53-2 13-methyl-17-(4-nitro-benzoyloxy)-2,14-dioxo-3,13,15-triazatricyclo-[13.3.0.0*4,6*]octadec-7-ene-4-carboxyric acid ethyl ester 
• 922726-54-3 17-hydroxy-13-methyl-2,14-dioxo-3,13,15-triaza-tricyclo[13.3.0.0*4.6*]-octadec-7-ene-4-carboxylic acid ethyl ester 
• 923274-85-5 4-nitro-benzoic acid (3S,5S)-5-((1R,2S)-1-ethoxycarbonyl-2-vinyl-cyclopropylcarbamoyl)-1-[hept-6-enyl-(4-methoxy-benzyl)-carbamoyl]-pyrrolidin-3-yl ester 

Relevant articles and documents

CALPAIN MODULATORS AND METHODS OF PRODUCTION AND USE THEREOF

The present technology relates to compounds, kits, compositions, and methods useful for the treatment of fibrotic disease. In some aspects, the present technology provides for treatment of various diseases or disorders associated or mediated, at least in part, by calpains, such as CAPN1, CAPN2, and/or CAPN9. The present technology is generally applicable to compounds which inhibit myofibroblast differentiation.

Macrocyclic compounds for suppressing replication of hepatitis C virus

A compound as represented by Formula (I) is provided, wherein groups are defined in the description. The compound is used as HCV protease inhibitor for treating HCV infection.

Dynamic kinetic resolution of dehydrocoronamic acid

Dehydrocoronamic acid can be racemised by dehydration of an N-acyl derivative to an azlactone, which undergoes facile racemisation. For the N-trifluoroacetyl derivative, the racemisation process was combined with an enzymatic resolution, to achieve a dynamic kinetic resolution process by which the racemate can be converted to either enantiomer. This journal is the Partner Organisations 2014.